Financhill
Buy
77

CAMT Quote, Financials, Valuation and Earnings

Last price:
$81.78
Seasonality move :
4.46%
Day range:
$77.31 - $82.51
52-week range:
$47.41 - $140.50
Dividend yield:
0%
P/E ratio:
31.25x
P/S ratio:
8.93x
P/B ratio:
6.33x
Volume:
1.5M
Avg. volume:
405.1K
1-year change:
-26.68%
Market cap:
$3.7B
Revenue:
$429.2M
EPS (TTM):
$2.61
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $155.9M $269.7M $320.9M $315.4M $429.2M
Revenue Growth (YoY) 16.3% 73.02% 19.01% -1.73% 36.1%
 
Cost of Revenues $82.6M $132.3M $161.1M $167.7M $219.3M
Gross Profit $73.2M $137.3M $159.9M $147.6M $210M
Gross Profit Margin 46.99% 50.93% 49.81% 46.81% 48.91%
 
R&D Expenses $19.6M $23.5M $28.9M $31.5M $38.3M
Selling, General & Admin $31M $43M $49.5M $50.8M $63.6M
Other Inc / (Exp) -$351K $58K -$351K -$78K $37K
Operating Expenses $50.6M $66.4M $78.4M $82.2M $101.9M
Operating Income $22.6M $70.9M $81.5M $65.4M $108.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $23.4M $71.9M $88.2M $87.6M $131.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.6M $11.7M $8.2M $9M $12.7M
Net Income to Company $21.8M $60.3M $79.9M $78.6M $118.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $21.8M $60.3M $79.9M $78.6M $118.5M
 
Basic EPS (Cont. Ops) $0.55 $1.38 $1.81 $1.76 $2.62
Diluted EPS (Cont. Ops) $0.54 $1.34 $1.68 $1.63 $2.42
Weighted Average Basic Share $39.4M $43.6M $44.2M $44.7M $45.3M
Weighted Average Diluted Share $40.4M $45M $48.2M $48.9M $49.4M
 
EBITDA $25.8M $75.2M $93.4M $94.5M $143M
EBIT $23.6M $72.4M $89.3M $88.7M $132.3M
 
Revenue (Reported) $155.9M $269.7M $320.9M $315.4M $429.2M
Operating Income (Reported) $22.6M $70.9M $81.5M $65.4M $108.1M
Operating Income (Adjusted) $23.6M $72.4M $89.3M $88.7M $132.3M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $57.4M $77.2M $72.5M $97M $118.6M
Revenue Growth (YoY) 90.04% 34.55% -6.1% 33.89% 22.3%
 
Cost of Revenues $28.4M $37.3M $38.6M $52.3M $58.1M
Gross Profit $29M $39.9M $33.9M $44.7M $60.6M
Gross Profit Margin 50.53% 51.65% 46.74% 46.1% 51.05%
 
R&D Expenses $5.5M $7.7M $7.6M $8.9M $10.4M
Selling, General & Admin $9.1M $12.7M $12.1M $14.6M $17.5M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $14.6M $20.3M $19.7M $23.5M $27.9M
Operating Income $14.4M $19.5M $14.2M $21.2M $32.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $14.8M $20.2M $19.3M $26.8M $38.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.4M $1.8M $2.1M $2M $3.8M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $13.4M $18.4M $17.2M $24.8M $34.3M
 
Basic EPS (Cont. Ops) $0.31 $0.42 $0.39 $0.55 $0.75
Diluted EPS (Cont. Ops) $0.30 $0.39 $0.36 $0.51 $0.70
Weighted Average Basic Share $43.3M $43.9M $44.5M $45.1M $45.6M
Weighted Average Diluted Share $44.5M $48.1M $48.4M $49.3M $49.3M
 
EBITDA $14.4M $19.5M $14.2M $21.2M $32.7M
EBIT $14.4M $19.5M $14.2M $21.2M $32.7M
 
Revenue (Reported) $57.4M $77.2M $72.5M $97M $118.6M
Operating Income (Reported) $14.4M $19.5M $14.2M $21.2M $32.7M
Operating Income (Adjusted) $14.4M $19.5M $14.2M $21.2M $32.7M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $183M $289.5M $316.2M $339.9M $450.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $94.4M $141.2M $162.3M $181.4M $225.1M
Gross Profit $88.7M $148.2M $153.9M $158.5M $225.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $20.9M $25.7M $28.7M $32.8M $39.7M
Selling, General & Admin $33.6M $46.5M $49M $53.2M $66.5M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $54.5M $72.2M $77.7M $86M $106.3M
Operating Income $34.2M $76M $76.2M $72.5M $119.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $34.9M $77.3M $87.3M $95.2M $142.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.6M $12M $8.5M $9M $14.5M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $32.4M $65.3M $78.8M $86.2M $128M
 
Basic EPS (Cont. Ops) $0.79 $1.49 $1.79 $1.92 $2.81
Diluted EPS (Cont. Ops) $0.76 $1.43 $1.64 $1.77 $2.61
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $36.8M $79.7M $84M $95.8M $155M
EBIT $35.1M $77.5M $84M $95.8M $155M
 
Revenue (Reported) $183M $289.5M $316.2M $339.9M $450.9M
Operating Income (Reported) $34.2M $76M $76.2M $72.5M $119.5M
Operating Income (Adjusted) $35.1M $77.5M $84M $95.8M $155M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $57.4M $77.2M $72.5M $97M $118.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $28.4M $37.3M $38.6M $52.3M $58.1M
Gross Profit $29M $39.9M $33.9M $44.7M $60.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $5.5M $7.7M $7.6M $8.9M $10.4M
Selling, General & Admin $9.1M $12.7M $12.1M $14.6M $17.5M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $14.6M $20.3M $19.7M $23.5M $27.9M
Operating Income $14.4M $19.5M $14.2M $21.2M $32.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $14.8M $20.2M $19.3M $26.8M $38.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.4M $1.8M $2.1M $2M $3.8M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $13.4M $18.4M $17.2M $24.8M $34.3M
 
Basic EPS (Cont. Ops) $0.31 $0.42 $0.39 $0.55 $0.75
Diluted EPS (Cont. Ops) $0.30 $0.39 $0.36 $0.51 $0.70
Weighted Average Basic Share $43.3M $43.9M $44.5M $45.1M $45.6M
Weighted Average Diluted Share $44.5M $48.1M $48.4M $49.3M $49.3M
 
EBITDA $14.4M $19.5M $14.2M $21.2M $32.7M
EBIT $14.4M $19.5M $14.2M $21.2M $32.7M
 
Revenue (Reported) $57.4M $77.2M $72.5M $97M $118.6M
Operating Income (Reported) $14.4M $19.5M $14.2M $21.2M $32.7M
Operating Income (Adjusted) $14.4M $19.5M $14.2M $21.2M $32.7M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $105.8M $241.9M $148.2M $120M $126.2M
Short Term Investments $72M $156M $251.5M $234.1M $261.8M
Accounts Receivable, Net $41M $57.8M $80.6M $87.3M $99.5M
Inventory $39.7M $58.8M $65.5M $85.9M $111.2M
Prepaid Expenses $455K $2M $3.8M $5.2M $5.5M
Other Current Assets $435K $542K $747K $2.3M $1.1M
Total Current Assets $261.9M $520.2M $557M $546.8M $620.1M
 
Property Plant And Equipment $20.4M $25.4M $33.1M $42M $54.2M
Long-Term Investments -- $32M $79M $94.6M $113.1M
Goodwill -- -- -- $74.3M $74.3M
Other Intangibles $609K $610K $597K $16.9M $13.4M
Other Long-Term Assets $4.5M $5.3M $6.4M $10.4M $13.9M
Total Assets $287.9M $583.8M $677.1M $787.7M $892M
 
Accounts Payable $27.2M $33.6M $31.7M $42.2M $46.6M
Accrued Expenses $4.9M $5.8M $4.7M $6.1M $7.4M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $736K $1M $1.3M $1.7M $2.5M
Other Current Liabilities $8.7M $27.5M $18M $13.6M $12.7M
Total Current Liabilities $57.4M $89.7M $88.5M $96.7M $123.9M
 
Long-Term Debt -- $194.6M $195.7M $196.8M $197.9M
Capital Leases -- -- -- -- --
Total Liabilities $60.6M $290.1M $293M $311.5M $342.8M
 
Common Stock $171K $172K $175K $176K $177K
Other Common Equity Adj -- -- -- $129K $203K
Common Equity $227.3M $293.6M $384.1M $476.1M $549.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $227.3M $293.6M $384.1M $476.1M $549.2M
 
Total Liabilities and Equity $287.9M $583.8M $677.1M $787.7M $892M
Cash and Short Terms $177.8M $397.9M $399.7M $354M $388M
Total Debt -- $194.6M $195.7M $196.8M $197.9M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $54.9M $76.3M $189.2M $123M $229.8M
Short Term Investments $115M $307M $226.5M $254.2M $191.7M
Accounts Receivable, Net $54.4M $72.5M $66.3M $86.4M $100.4M
Inventory $44.6M $63.8M $64.5M $92.1M $129.2M
Prepaid Expenses -- -- -- -- --
Other Current Assets $4M $6.9M $15M $23.3M $22.9M
Total Current Assets $273M $526.5M $561.6M $578.9M $674M
 
Property Plant And Equipment $20.5M $28.8M $35.2M $42.8M $55M
Long-Term Investments $10M $45M $77M $89.8M $101.1M
Goodwill -- -- -- $74.3M $74.3M
Other Intangibles -- -- -- $16M $12.5M
Other Long-Term Assets $4.6M $5.5M $8.1M $11.8M $14M
Total Assets $308.7M $606.7M $683.4M $816.3M $934M
 
Accounts Payable $27.3M $37.9M $28.1M $38.9M $48.1M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $36M $52.9M $46.4M $59.2M $79.6M
Total Current Liabilities $63.4M $90.8M $74.5M $158.1M $127.7M
 
Long-Term Debt -- $194.9M $196M $197.1M $198.2M
Capital Leases -- -- -- -- --
Total Liabilities $66.7M $292M $278.8M $372.7M $346.1M
 
Common Stock $171K $172K $175K $176K $177K
Other Common Equity Adj -- -- -- -$410K $795K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $242M $314.7M $404.5M $443.6M $587.9M
 
Total Liabilities and Equity $308.7M $606.7M $683.4M $816.3M $934M
Cash and Short Terms $169.9M $383.3M $415.7M $377.2M $421.5M
Total Debt -- $194.9M $196M $197.1M $198.2M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $21.8M $60.3M $79.9M $78.6M $118.5M
Depreciation & Amoritzation $2.2M $2.8M $4.1M $5.8M $10.7M
Stock-Based Compensation $4.2M $5.8M $10.5M $12.6M $14.5M
Change in Accounts Receivable -$9.6M -$17.4M -$22M -$1.9M -$12.2M
Change in Inventories -$19.3M -$21.7M -$9.5M -$13.7M -$32.2M
Cash From Operations $25.8M $61M $57.8M $79.3M $122.2M
 
Capital Expenditures $2.6M $4.2M $8.3M $8.3M $10.4M
Cash Acquisitions -- -- -- -$101.8M $1.3M
Cash From Investing -$23.1M -$120.2M -$150.8M -$107.5M -$55.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$60M
Special Dividend Paid
Long-Term Debt Issued -- $194.5M -- -- --
Long-Term Debt Repaid -- -- -- -- -$42K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $64.9M $194.8M $3K $182K -$60M
 
Beginning Cash (CF) $38M $105.8M $241.9M $148.2M $120M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $67.5M $135.6M -$93M -$27.9M $6.3M
Ending Cash (CF) $105.8M $241.9M $148.2M $120M $126.2M
 
Levered Free Cash Flow $23.1M $56.8M $49.5M $71.1M $111.9M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders $8.1M $29M $37.6M $35.8M $52.8M
Depreciation & Amoritzation $1.1M $1.3M $1.8M $2.4M $5M
Stock-Based Compensation $1.8M $2.7M $5.6M $6.5M $7.2M
Change in Accounts Receivable -$8.1M -$19.2M -$14.3M $1.8M $19.3M
Change in Inventories -$7M -$15.2M -$13.5M $171K -$14.5M
Cash From Operations $12.5M $22.6M $12.9M $32.7M $70.1M
 
Capital Expenditures $901K $1.3M $3.8M $4.8M $5.3M
Cash Acquisitions -- -- -- -- $1.3M
Cash From Investing -$18.4M -$48.3M -$197.8M $52.2M -$43.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$60M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $334K $206K $2K -- -$60M
 
Beginning Cash (CF) $38M $105.8M $241.9M $148.2M $120M
Foreign Exchange Rate Adjustment $23K $9K -$1M -$243K -$230K
Additions / Reductions -$5.6M -$25.5M -$184.9M $84.9M -$33.5M
Ending Cash (CF) $32.5M $80.3M $56M $232.8M $86.2M
 
Levered Free Cash Flow $11.6M $21.3M $9.1M $27.9M $64.9M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $4.8M $6.9M $5.6M $6.5M $7.2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures $2.5M $3.9M $3.8M $4.8M $5.3M
Cash Acquisitions -- -- -- -- $1.3M
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$60M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders $29M $37.6M $35.8M $52.8M --
Depreciation & Amoritzation $1.3M $1.8M $2.4M $5M --
Stock-Based Compensation $2.7M $5.6M $6.5M $7.2M --
Change in Accounts Receivable -$19.2M -$14.3M $1.8M $19.3M --
Change in Inventories -$15.2M -$13.5M $171K -$14.5M --
Cash From Operations $22.6M $12.9M $32.7M $70.1M --
 
Capital Expenditures $1.3M $3.8M $4.8M $5.3M --
Cash Acquisitions -- -- -- $1.3M --
Cash From Investing -$48.3M -$197.8M $52.2M -$43.7M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -$60M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $206K $2K -- -$60M --
 
Beginning Cash (CF) $105.8M $241.9M $148.2M $120M --
Foreign Exchange Rate Adjustment $9K -$1M -$243K -$230K --
Additions / Reductions -$25.5M -$184.9M $84.9M -$33.5M --
Ending Cash (CF) $80.3M $56M $232.8M $86.2M --
 
Levered Free Cash Flow $21.3M $9.1M $27.9M $64.9M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is NuScale the Best Nuclear Stock to Buy?
Is NuScale the Best Nuclear Stock to Buy?

NuScale Power (NYSE:SMR) is a nuclear power startup that has…

Where Will Kestra Medical Stock Be in 1 Year?
Where Will Kestra Medical Stock Be in 1 Year?

Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…

Why Did Howard Marks Buy Grab Stock?
Why Did Howard Marks Buy Grab Stock?

When a legendary value investor who cut his teeth in…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 42x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 50x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
59
NKTR alert for Jun 25

Nektar Therapeutics [NKTR] is up 20.45% over the past day.

Buy
58
AMBA alert for Jun 25

Ambarella [AMBA] is up 3.71% over the past day.

Buy
65
EXOD alert for Jun 25

Exodus Movement [EXOD] is down 8.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock